Grants and Contributions:

Title:
Eliminating Cervical Cancer in Canada
Agreement Number:
154623
Agreement Value:
$10,090,731.00
Agreement Date:
Apr 1, 2019 - Dec 31, 2024
Description:
The Eliminating Cervical Cancer in Canada funding opportunity is expected to: • Maintain and/or strengthen a high quality research program for implementation science, clinical, health services, and population health research to achieve better clinical, economic, and population health outcomes related to the elimination of cervical cancer for the benefit of Canadians; • Examine the effectiveness of HPV vaccine schedules, including 1 dose schedules; • Evaluate the requirement for booster doses for the HPV vaccine for males and females; • Improve understanding of, access to, and uptake of cervical cancer screening among underserved populations with appropriate consideration of income, cultural background, geographic location, education, gender, and other intersecting factors; • Improve understanding of, access to, and uptake of HPV vaccination among the general population, including consideration of the role of parents and guardians, as well as appropriate consideration of how income, cultural background, geographic location, education, gender, and other intersecting factors may be contributing to vaccine hesitancy; • Assess the feasibility, suitability and implementation of HPV self-collection for underscreened populations with appropriate consideration of how income, cultural background, geographic location, education, gender, and other intersecting factors may affect effective implementation; and • Establish a network of collaborative centres to ensure that good practices and learnings from the grant recipients are translated nationally to maximize the impact and outcomes of the research program across jurisdictions for the benefit of Canadians.
Organization:
Canadian Institutes of Health Research
Expected Results:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Location:
Vancouver, British Columbia, CA V6H 3N1
Reference Number:
236-2019-2020-Q4-00297
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Additional Information:

Amendment 1: Agreement Value in CAD. Amendment 2: Projected Agreement End Date.

Amendment Date
Dec 31, 2020
Recipient's Legal Name:
Ogilvie, Gina S
Research Organization:
BC Women's Health Foundation
Program:
Research in Priority Areas
Program Purpose:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Amendments: